ஈரமான வாழ்நாள் தொடர்புடையது மாகுலர் சீரழிவு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

This Is Why Ocugen Crashed Despite Apparent Good News InvestorPlace 5/10/2021 Ocugen (NASDAQ: OCGN) stock was a late entrant into the Covid-19 vaccine race. OCGN stock traded for less than $1 per share through December 2020. Then, however, it announced a transformative deal with India’s Bharat Biotech, and shares popped as much as 3,000% since then. © Provided by InvestorPlace The concept image of a vaccine passport with a needle and map. As recently as a week ago, traders were rushing to buy OCGN stock; shares doubled in late April and hit $16 at their recent peak in the first days of May. Since then, however, Ocugen shares lost nearly half their value in a few days of frenzied selling. What explains Ocugen’s sudden rise and equally speedy fall?

South africaUnited statesUnited kingdomSouth africanShutterstock theBharat biotechInvestorplace theDiabetic macular edemaDiabetic retinopathyWet age related macular degenerationஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்பாரத் பயோடெக்நீரிழிவு மாகுலர் எடிமாநீரிழிவு ரெட்டினோபதிஈரமான வாழ்நாள் தொடர்புடையது மாகுலர் சீரழிவு